Skip to main content
Clinical Trials/NCT04073654
NCT04073654
Unknown
N/A

Clinical Evaluation and Primary Stability of Early Loaded Implants With Sandblasted and Acid-etched Surface Versus Implants With SA Surface Modified With pH Buffering Agent: a Multicenter Randomized Controlled Trial

Osstem AIC10 sites in 8 countries100 target enrollmentSeptember 26, 2019

Overview

Phase
N/A
Intervention
Not specified
Conditions
Dental Implant Failed
Sponsor
Osstem AIC
Enrollment
100
Locations
10
Primary Endpoint
Implant failure
Last Updated
6 years ago

Overview

Brief Summary

The purpose of this randomized controlled trial is to compare clinical data and implant stability of immediately loaded TSIII Osstem implants with Sandblasted and Acid-etched (SA) surface versus implants with SA surface modified with pH buffering agent for the rehabilitation of single implant-supported crown.

Detailed Description

This study aimed to evaluate if there are some benefits using novel implant surface. This surface should improve the secondary implant stability, reducing the overall time needed for the osseointegration. main benefits in clinical practice should be reduced treatment time.

Registry
clinicaltrials.gov
Start Date
September 26, 2019
End Date
October 15, 2021
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Osstem AIC
Responsible Party
Principal Investigator
Principal Investigator

Marco Tallarico

Coordinator

Osstem AIC

Eligibility Criteria

Inclusion Criteria

  • Any partially edentulous subject requiring at least two single (preferable non-adjacent) implant-supported crowns, being at least 18 year old and able to sign an informed consent will be screened for eligibility. Bone volumes should allow the placement of two implants at least 8.5 mm (maximum 10 mm) long and 4.5 mm (minimum 3.5 mm) wide, with a minimal insertion torque of 30 Ncm. Implants can be placed in previous post-extractive socket or in augmented bone, if at least 4 to 6 months have passed from the extraction or from augmentation procedures.

Exclusion Criteria

  • Patients unable to commit to 5 years follow-up.
  • General contraindications to implant surgery.
  • Less then 4 mm of keratinised gingiva crestally (at the implant sites).
  • Immune-suppressed/compromised patients.
  • Patients irradiated in the head and/or neck.
  • Uncontrolled diabetes.
  • Pregnancy or lactation.
  • Untreated periodontal disease.
  • Poor oral hygiene and motivation (full mouth bleeding and full mouth plaque index higher than 25%).
  • Addiction to alcohol or drugs.

Outcomes

Primary Outcomes

Implant failure

Time Frame: From implant placement up to 60 months after loading

Implant removal for any reason will be considered an implant failure.

Crown failure

Time Frame: From crown delivery up to 60 months

Crown replacement for any reason will be considered a crown failure.

Complications

Time Frame: From implant placement up to 60 months after loading

Any complications will be recorded. Examples of biological complications are: nerve injury, fistula, peri-implantitis. Examples of biomechanical complications are fracture of the abutments screw, loosening of the crown, fracture of the ceramic.

Secondary Outcomes

  • Peri-implant marginal bone level (MBL) changes(From implant placement up to 60 months after loading)
  • Probing pocket depth (PPD)(From crown delivery up to 60 months)
  • Bleeding on probing (BOP)(From crown delivery up to 60 months)
  • plaque index (PI)(From implant placement up to 60 months after loading)
  • Implant stability quotient(The ISQ values will be recorded at the time of implant placement (baseline) and then 1,2,3,4,5,6,7,8, and 12 weeks after implant placement.)
  • Pink Esthetic Score(From crown delivery up to 60 months)

Study Sites (10)

Loading locations...

Similar Trials